Cargando…

Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis

BACKGROUND: Pregnancy is associated with reduced activity of multiple sclerosis (MS). However, the biological mechanisms underlying this pregnancy-related decrease in disease activity are poorly understood. METHODOLOGY: We conducted a genome-wide transcription analysis in peripheral blood mononuclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilli, Francesca, Lindberg, Raija L. P., Valentino, Paola, Marnetto, Fabiana, Malucchi, Simona, Sala, Arianna, Capobianco, Marco, di Sapio, Alessia, Sperli, Francesca, Kappos, Ludwig, Calogero, Raffaele A., Bertolotto, Antonio
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813302/ https://www.ncbi.nlm.nih.gov/pubmed/20126412 http://dx.doi.org/10.1371/journal.pone.0008962

Ejemplares similares

Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy
por: Motuzova, Yana, et al.
Publicado: (2015)

Normative Values for Intertrial Variability of Motor Responses to Nerve Root and Transcranial Stimulation: A Condition for Follow-Up Studies in Individual Subjects
por: Troni, Walter, et al.
Publicado: (2016)

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
por: Malucchi, Simona, et al.
Publicado: (2016)

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study
por: Bruschi, Nicolò, et al.
Publicado: (2023)

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study
por: Valentino, Paola, et al.
Publicado: (2016)

The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line
por: Montarolo, Francesca, et al.
Publicado: (2022)

The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes
por: Martire, Serena, et al.
Publicado: (2022)

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
por: Marcinnò, Andrea, et al.
Publicado: (2018)

Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers
por: Lo Re, Marianna, et al.
Publicado: (2015)

Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology
por: Granieri, Letizia, et al.
Publicado: (2012)

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis
por: Perga, Simona, et al.
Publicado: (2015)

PARP-1 deregulation in multiple sclerosis
por: Meira, Maria, et al.
Publicado: (2019)

Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis
por: Meira, Maria, et al.
Publicado: (2014)

Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy
por: Mehling, Matthias, et al.
Publicado: (2013)

Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis
por: Veroni, Caterina, et al.
Publicado: (2015)

Natalizumab treatment reduces L-selectin (CD62L) in CD4(+) T cells
por: Spadaro, Michela, et al.
Publicado: (2015)

NURR1 Impairment in Multiple Sclerosis
por: Montarolo, Francesca, et al.
Publicado: (2019)

Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study
por: Borghi, Martina, et al.
Publicado: (2016)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial
por: Carletto, Sara, et al.
Publicado: (2016)

Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue
por: Spadaro, Michela, et al.
Publicado: (2019)

Presence and Significant Determinants of Cognitive Impairment in a Large Sample of Patients with Multiple Sclerosis
por: Borghi, Martina, et al.
Publicado: (2013)

The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial
por: Carletto, Sara, et al.
Publicado: (2017)

Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis
por: Callegari, Ilaria, et al.
Publicado: (2023)

Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis
por: Diebold, Martin, et al.
Publicado: (2022)

SeXX Matters in Multiple Sclerosis
por: Gilli, Francesca, et al.
Publicado: (2020)

Anal sphincter dysfunction in multiple sclerosis: an observation manometric study
por: Marola, Silvia, et al.
Publicado: (2016)

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis
por: DiSano, Krista D, et al.
Publicado: (2020)

Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
por: DiSano, Krista D., et al.
Publicado: (2021)

Theiler’s virus-induced demyelinating disease as an infectious model of progressive multiple sclerosis
por: Pike, Steven C., et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
por: Bertolotto, Antonio, et al.
Publicado: (2020)

Efficacy and Safety of Fingolimod in an Unselected Patient Population
por: Rasenack, Maria, et al.
Publicado: (2016)

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis
por: Baranzini, Sergio E., et al.
Publicado: (2009)

Divergent complement system activation in two clinically distinct murine models of multiple sclerosis
por: Linzey, Michael, et al.
Publicado: (2022)

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
por: Comi, Giancarlo, et al.
Publicado: (2020)

High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis
por: Gilli, Francesca, et al.
Publicado: (2016)

Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis
por: DiSano, Krista D., et al.
Publicado: (2019)

Microstructure-Weighted Connectomics in Multiple Sclerosis
por: Bosticardo, Sara, et al.
Publicado: (2022)

Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development
por: Meira, Maria, et al.
Publicado: (2016)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_csli5ma7sf35i9jle8t3pf4q5i